| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AC19 |
| UNII: | YB18NF020M |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | IL6Ralpha/GP130 antagonist |
| Primary Target | |
|---|---|
| Interleukin-6 receptor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Encephalitis, Japanese | 3 | D004672 | ClinicalTrials |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Graves Ophthalmopathy | 3 | D049970 | ClinicalTrials |
| Muscular Dystrophy, Duchenne | 2 | D020388 | ClinicalTrials |
| Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3833307 |
| FDA SRS | YB18NF020M |
| Guide to Pharmacology | 9093 |
CONTENTS